Patents by Inventor Daniel M. Jones
Daniel M. Jones has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11601324Abstract: An application executing on a mobile computing platform provides independent data channels over a mobile network to multiple separate computing systems that each maintain some data pertinent to problem determination and resolution when an incident arises in a monitored information technology (IT) environment. The application maintains and separately exercises the channels to provide timely information in a user interface that composites data to present a single interface with a multi-sourced contextual rendering. Some systems may include an IT monitoring system and a separate incident management system among its sources. Channels may include extended functionality to improve security or other aspects of communication with mobile platforms.Type: GrantFiled: March 10, 2022Date of Patent: March 7, 2023Assignee: SPLUNK INC.Inventors: Tristan Antonio Fletcher, Caleb Eugene Hanson, Amy Katherine Hunnel Bianchi, Daniel M. Jones, Alexandros Nikolaos Kompotis, Ross Andrew Lazerowitz, William Marcum, Michael Margulis, Sean David McBride, Daniel Blake Partain, Eric Nathaniel Tschetter, Dipti Prabhakar Siddamsettiwar
-
Patent number: 11303503Abstract: An application executing on a mobile computing platform provides independent data channels over a mobile network to multiple separate computing systems that each maintain some data pertinent to problem determination and resolution when an incident arises in a monitored information technology (IT) environment. The application maintains and separately exercises the channels to provide timely information in a user interface that composites data to present a single interface with a multi-sourced contextual rendering. Some systems may include an IT monitoring system and a separate incident management system among its sources. Channels may include extended functionality to improve security or other aspects of communication with mobile platforms.Type: GrantFiled: December 3, 2020Date of Patent: April 12, 2022Assignee: SPLUNK INC.Inventors: Tristan Antonio Fletcher, Caleb Eugene Hanson, Amy Katherine Hunnel Bianchi, Daniel M. Jones, Alexandros Nikolaos Kompotis, Ross Andrew Lazerowitz, William Marcum, Michael Margulis, Sean David McBride, Daniel Blake Partain, Eric Nathaniel Tschetter, Dipti Prabhakar Siddamsettiwar
-
Patent number: 11118232Abstract: Described herein are methods for diagnosing melanoma or basal cell carcinoma based on mutations in the DDR2 gene. Further, a distinct subgroup of BRAF-mutated melanomas have somatic mutations in the DDR2 gene as well. Applications of this finding to routine diagnostics include the molecular stratification of melanoma, and the tissue identification of targetable DDR2 kinase mutations in routine formalin-fixed paraffin-embedded sections. Described herein are methods, compositions and kits related to the discovery that DDR2 mutations may be markers for melanoma generally, and BRAF-mediated melanoma in particular, opening up the possibility of dual therapy for melanoma by targeting both DDR2 and BRAF.Type: GrantFiled: December 17, 2018Date of Patent: September 14, 2021Assignee: Quest Diagnostics Investments LLCInventors: Daniel M. Jones, Yongbao Wang, Shere Billouin-Frazier, Justin Windham
-
Patent number: 11023511Abstract: An application executing on a mobile computing platform provides independent data channels over a mobile network to multiple separate computing systems that each maintain some data pertinent to problem determination and resolution when an incident arises in a monitored information technology (IT) environment. The application maintains and separately exercises the channels to provide timely information in a user interface that composites data to present a single interface with a multi-sourced contextual rendering. Some systems may include an IT monitoring system and a separate incident management system among its sources. Channels may include extended functionality to improve security or other aspects of communication with mobile platforms.Type: GrantFiled: July 31, 2019Date of Patent: June 1, 2021Assignee: SPLUNK INC.Inventors: Tristan Antonio Fletcher, Caleb Eugene Hanson, Amy Katherine Hunnel Bianchi, Daniel M. Jones, Alexandros Nikolaos Kompotis, Ross Andrew Lazerowitz, William Marcum, Michael Margulis, Sean David McBride, Daniel Blake Partain, Eric Nathaniel Tschetter, Dipti Prabhakar Siddamsettiwar
-
Patent number: 10887157Abstract: An application executing on a mobile computing platform provides independent data channels over a mobile network to multiple separate computing systems that each maintain some data pertinent to problem determination and resolution when an incident arises in a monitored information technology (IT) environment. The application maintains and separately exercises the channels to provide timely information in a user interface that composites data to present a single interface with a multi-sourced contextual rendering. Some systems may include an IT monitoring system and a separate incident management system among its sources. Channels may include extended functionality to improve security or other aspects of communication with mobile platforms.Type: GrantFiled: July 31, 2019Date of Patent: January 5, 2021Assignee: SPLUNK INC.Inventors: Tristan Antonio Fletcher, Caleb Eugene Hanson, Amy Katherine Hunnel Bianchi, Daniel M. Jones, Alexandros Nikolaos Kompotis, Ross Andrew Lazerowitz, William Marcum, Michael Margulis, Sean David McBride, Daniel Blake Partain, Eric Nathaniel Tschetter, Dipti Prabhakar Siddamsettiwar
-
Publication number: 20190177801Abstract: Described herein are methods for diagnosing melanoma or basal cell carcinoma based on mutations in the DDR2 gene. Further, a distinct subgroup of BRAF-mutated melanomas have somatic mutations in the DDR2 gene as well. Applications of this finding to routine diagnostics include the molecular stratification of melanoma, and the tissue identification of targetable DDR2 kinase mutations in routine formalin-fixed paraffin-embedded sections. Described herein are methods, compositions and kits related to the discovery that DDR2 mutations may be markers for melanoma generally, and BRAF-mediated melanoma in particular, opening up the possibility of dual therapy for melanoma by targeting both DDR2 and BRAF.Type: ApplicationFiled: December 17, 2018Publication date: June 13, 2019Applicant: QUEST DIAGNOSTICS INVESTMENTS LLCInventors: Daniel M. Jones, Yongbao Wang, Shere Billouin-Frazier, Justin Windham
-
Patent number: 10155994Abstract: Described herein are methods for diagnosing melanoma or basal cell carcinoma based on mutations in the DDR2 gene. Further, a distinct subgroup of BRAF-mutated melanomas have somatic mutations in the DDR2 gene as well. Applications of this finding to routine diagnostics include the molecular stratification of melanoma, and the tissue identification of targetable DDR2 kinase mutations in routine formalin-fixed paraffin-embedded sections. Described herein are methods, compositions and kits related to the discovery that DDR2 mutations may be markers for melanoma generally, and BRAF-mediated melanoma in particular, opening up the possibility of dual therapy for melanoma by targeting both DDR2 and BRAF.Type: GrantFiled: March 10, 2017Date of Patent: December 18, 2018Assignee: Quest Diagnostics Investments IncorporatedInventors: Daniel M. Jones, Yongbao Wang, Shere Billouin-Frazier, Justin Windham
-
Publication number: 20170260591Abstract: Described herein are methods for diagnosing melanoma or basal cell carcinoma based on mutations in the DDR2 gene. Further, a distinct subgroup of BRAF-mutated melanomas have somatic mutations in the DDR2 gene as well. Applications of this finding to routine diagnostics include the molecular stratification of melanoma, and the tissue identification of targetable DDR2 kinase mutations in routine formalin-fixed paraffin-embedded sections. Described herein are methods, compositions and kits related to the discovery that DDR2 mutations may be markers for melanoma generally, and BRAF-mediated melanoma in particular, opening up the possibility of dual therapy for melanoma by targeting both DDR2 and BRAF.Type: ApplicationFiled: March 10, 2017Publication date: September 14, 2017Applicant: QUEST DIAGNOSTICS INVESTMENTS INCORPORATEDInventors: Daniel M. Jones, Yongbao Wang, Shere Billouin-Frazier, Justin Windham
-
Patent number: 9617579Abstract: Described herein are methods for diagnosing melanoma or basal cell carcinoma based on mutations in the DDR2 gene. Further, a distinct subgroup of BRAF-mutated melanomas have somatic mutations in the DDR2 gene as well. Applications of this finding to routine diagnostics include the molecular stratification of melanoma, and the tissue identification of targetable DDR2 kinase mutations in routine formalin-fixed paraffin-embedded sections. Described herein are methods, compositions and kits related to the discovery that DDR2 mutations may be markers for melanoma generally, and BRAF-mediated melanoma in particular, opening up the possibility of dual therapy for melanoma by targeting both DDR2 and BRAF.Type: GrantFiled: December 26, 2013Date of Patent: April 11, 2017Assignee: QUEST DIAGNOSTICS INVESTMENTS INCORPORATEDInventors: Daniel M. Jones, Yongbao Wang, Shere Billouin-Frazier, Justin Windham
-
Publication number: 20140220032Abstract: Described herein are methods for diagnosing melanoma or basal cell carcinoma based on mutations in the DDR2 gene. Further, a distinct subgroup of BRAF-mutated melanomas have somatic mutations in the DDR2 gene as well. Applications of this finding to routine diagnostics include the molecular stratification of melanoma, and the tissue identification of targetable DDR2 kinase mutations in routine formalin-fixed paraffin-embedded sections. Described herein are methods, compositions and kits related to the discovery that DDR2 mutations may be markers for melanoma generally, and BRAF-mediated melanoma in particular, opening up the possibility of dual therapy for melanoma by targeting both DDR2 and BRAF.Type: ApplicationFiled: December 26, 2013Publication date: August 7, 2014Applicant: QUEST DIAGNOSTICS INVESTMENTS INCORPORATEDInventors: DANIEL M. JONES, YONGBAO WANG, SHERE BILLOUIN-FRAZIER, JUSTIN WINDHAM
-
Publication number: 20110191328Abstract: A system and method for extracting representative media content from an online document is described. One illustrative embodiment identifies a content section in the electronic document; identifies one or more media items referenced or contained in the content section; identifies, among the one or more media items, at least one image that satisfies one or more predetermined criteria applied during an analysis pertaining to the one or more media items; selects, from among the at least one image that satisfies the one or more predetermined criteria, a particular image as the representative image; and stores information about the representative image.Type: ApplicationFiled: December 23, 2010Publication date: August 4, 2011Inventors: Todd H. Vernon, Emmanuel Puentes, William H. Marcum, III, Daniel M. Jones, Randal W. Brumbaugh